Multitarget kinase inhibitor (unspecified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Multitarget kinase inhibitor (unspecified), covering 2025-07-24 to 2025-07-24. Get the full timeline:
Most recent: Clinical Trial Update: Multiple Target Kinase Inhibitor and Anti-Programmed Death-1 Antibody in Patients With Advanced Thyroid Cancer [Phase 2]